Back to Markets

LLY vs TMO

A side-by-side look at LLY and TMO, updated throughout the trading session.

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…
Live figures are refreshing. Check back in a moment.

LLY vs TMO: how they differ

Eli Lilly and Company (LLY) and Thermo Fisher Scientific Inc. (TMO) are both in the Healthcare sector: LLY is classified in Drug Manufacturers - General, TMO in Medical - Diagnostics & Research. Both trade on NYSE.

LLY trades about 2.6 million shares a day on average, against 2.2 million for TMO. TMO has the higher beta (0.88 against 0.45 for LLY), meaning it has historically moved more with the broad market. Over the trailing twelve months, LLY paid $6.69 per share in dividends and TMO paid $1.84 per share.

Figures as of October 25, 2026.

More comparisons

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.